IP Library Granted Patent US 10,335,221
Granted Patent B2
US 10,335,221 · App. 15/686,265 · Granted Jul 2, 2019

Methods and devices to treat nasal airways

Inventors: Scott J. Wolf (Menlo Park, CA); Andrew Frazier (Sunnyvale, CA)
Assignee: AERIN MEDICAL, INC.
A61B18/02A61B5/01A61B17/2816A61B18/06A61B18/085A61B18/1206A61B18/14A61B18/1442A61B18/1445A61B18/1477A61B18/1485A61B18/16A61B18/1815A61B18/20A61F5/08A61F5/56A61F7/10A61N1/403A61N5/025A61N5/0603A61N5/0625A61N7/022A61B17/320068A61B2017/248A61B2018/00005A61B2018/0016A61B2018/0022A61B2018/00023A61B2018/0091A61B2018/00178A61B2018/00327A61B2018/00577A61B2018/00595A61B2018/00642A61B2018/00702A61B2018/00708A61B2018/00791A61B2018/00821A61B2018/00875A61B2018/00886A61B2018/00922A61B2018/00982A61B2018/00994A61B2018/0212A61B2018/0225A61B2018/0262A61B2018/126A61B2018/1253A61B2018/143A61B2018/1425A61B2018/1807A61B2018/1861F04C2270/041
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,335,221
App. No.
15/686,265
Granted
Jul 2, 2019
Kind
B2
Abstract

Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.

Claims (26)

1. A method of treating an airway in a patient, the method comprising:

advancing a cryotherapy balloon of a treatment device through a nostril of the patient and into the airway in an uninflated configuration;

inflating the cryotherapy balloon by circulating a low-temperature liquid into an interior of the cryotherapy balloon, wherein inflating the cryotherapy balloon causes the cryotherapy balloon to contact nasal mucosa lining the airway;

removing energy from submucosal tissue underlying the nasal mucosa by maintaining the cryotherapy balloon in an inflated configuration and continuing to circulate the low-temperature liquid through the interior of the cryotherapy balloon, to change a property of the submucosal tissue;

deflating the cryotherapy balloon by removing the low-temperature liquid from the interior of cryotherapy balloon; and

removing the cryotherapy balloon from the airway.

2. A method as in claim 1 , wherein the cryotherapy balloon comprises a shape memory material, and wherein releasing the cryotherapy balloon from constraint within a delivery device causes the cryotherapy balloon to partially expand.

3. A method as in claim 1 , wherein the low-temperature liquid comprises liquid nitrogen.

4. A method as in claim 1 , wherein the submucosal tissue is selected from the group consisting of upper lateral cartilage, lower lateral cartilage, nasal septum within a nasal valve, nasal septum outside of a nasal valve, swell bodies located on a nasal septum, a septal turbinate, a high deviated nasal septum, a nasal scroll, a floor of a nasal cavity, a piriform area, and swell bodies on a floor of a nasal cavity.

5. A method as in claim 1 , wherein inflating the cryotherapy balloon causes expansion of the airway, and wherein the airway remains in at least a partially expanded shape after the cryotherapy balloon is removed from the airway.

6. The method of claim 1 , wherein removing the energy comprises changing the property of the submucosal tissue without reshaping the submucosal tissue.

7. The method of claim 1 , wherein the submucosal tissue is located in the airway away from a nasal valve.

8. A method of treating a nasal airway in a patient, the method comprising:

advancing a cryotherapy balloon of a treatment device through a nostril of the patient and into the nasal airway in an uninflated configuration;

inflating the cryotherapy balloon by circulating a low-temperature liquid into an interior of the cryotherapy balloon, wherein inflating the cryotherapy balloon causes the cryotherapy balloon to contact nasal mucosa lining the nasal airway;

delivering a cryotherapy treatment to a selected tissue depth beneath the nasal mucosa by continuing to circulate the low-temperature liquid through the cryotherapy balloon to change a property of a submucosal tissue underlying the nasal mucosa;

deflating the cryotherapy balloon by removing the low-temperature liquid from the interior of cryotherapy balloon; and

removing the cryotherapy balloon from the nasal airway.

9. The method of claim 8 , wherein the cryotherapy balloon is configured to deliver the cryotherapy treatment uniformly over an entire outer surface of the cryotherapy balloon.

10. The method of claim 8 , wherein delivering the cryotherapy treatment comprises delivering cryotherapy to the selected tissue depth in order to target the cryotherapy treatment at a specific submucosal tissue.

11. The method of claim 8 , wherein the low-temperature liquid comprises liquid nitrogen.

12. The method of claim 8 , further comprising allowing a shape memory material of the cryotherapy balloon to expand to a default shape upon release from a delivery device.

13. The method of claim 8 , wherein inflating the cryotherapy balloon causes expansion of the nasal airway, and wherein the nasal airway remains in at least a partially expanded shape after the cryotherapy balloon is removed.

14. The method of claim 8 , wherein the submucosal tissue is selected from the group consisting of upper lateral cartilage, lower lateral cartilage, nasal septum within a nasal valve, nasal septum outside of a nasal valve, swell bodies located on a nasal septum, a septal turbinate, a high deviated nasal septum, a nasal scroll, a floor of a nasal cavity, a piriform area, and swell bodies on a floor of a nasal cavity.

15. The method of claim 8 , wherein delivering the cryotherapy treatment comprises changing the property of the submucosal tissue without reshaping the submucosal tissue.

16. The method of claim 8 , wherein the submucosal tissue is located in the nasal airway away from a nasal valve.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2024
From: CRG SERVICING LLC
To: AERIN MEDICAL INC.
Reel/Frame 069654/0467 →
SECURITY INTEREST Recorded Dec 20, 2024
From: AERIN MEDICAL INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 069746/0508 →
SECURITY INTEREST Recorded May 13, 2019
From: AERIN MEDICAL INC.
To: CRG SERVICING LLC
Reel/Frame 049161/0043 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2017
From: WOLF, SCOTT J.; FRAZIER, ANDREW
To: AERIN MEDICAL INC.
Reel/Frame 043401/0083 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2017
From: WOLF, SCOTT J.; FRAZIER, ANDREW
To: AERIN MEDICAL, INC.
Reel/Frame 043401/0159 →
Continuity (7)
Continuation 15272007 · Sep 21, 2016
Continuation 14754087 · Jun 29, 2015
Continuation 14319087 · Jun 30, 2014
Continuation In Part 13495844 · Jun 13, 2012
Provisional Application 61603864 · Feb 27, 2012
Provisional Application 61496930 · Jun 14, 2011
Related Publication 20180000535A1 · Jan 4, 2018
Cited By (18)
US 12,245,803 US 12,268,433 US 12,279,808 US 12,336,750 US 12,357,378 US 12,357,817 US 12,364,532 US 12,369,963 US 12,369,966 US 12,369,973 US 12,446,953 US 12,471,978 US 12,484,957 US 12,527,618 US 12,558,536 US 12,636,058 US 12,636,073 US 12,678,212